Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Terveystalo

8.55 EUR

-4.68 %

12,175 following
Corporate customer

TTALO

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
-4.68 %
-8.95 %
-14.24 %
-12.58 %
-14.16 %
-27.17 %
+13.70 %
-28.03 %
-14.50 %

Terveystalo operates in the healthcare sector. The company offers services and solutions such as surveys and examinations, training and coaching, rehabilitation, and health and fitness mapping. Its customers include small and medium-sized corporate customers, as well as public sector players. The head office is located in Helsinki.

Read more
Market cap
1.09B EUR
Turnover
5.87M EUR
P/E (adj.) (26e)
11.16
EV/EBIT (adj.) (26e)
11.37
P/B (26e)
1.83
EV/S (26e)
1.3
Dividend yield-% (26e)
7.6 %
Coverage
Recommendation
Reduce
Target price
9.30 EUR
Updated
16.04.2026
Disclaimer
Roni Peuranheimo
Roni Peuranheimo

Analyst

Latest research

Latest analysis report

Released: 17.04.2026

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
24.4
2026

Interim report Q1'26

17.7
2026

Interim report Q2'26

7.10
2026

Half year dividend

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Terveystalo Q1'26 preview: Efterspørgselsudsigterne er udfordrende
Researchyesterday by
Roni Peuranheimo

Terveystalo Q1'26 preview: Efterspørgselsudsigterne er udfordrende

Efterspørgslen på det private sundhedsmarked har været svag i begyndelsen af året baseret på flere offentlige datapunkter.

Terveystalo
Analyst Comment4/1/2026, 5:14 AM by
Roni Peuranheimo

Mehiläinen fortsatte sin stærke opkøbsdrevne vækst i 2025

Mehiläinen fremskyndede sin vækst markant sidste år, men hovedsageligt ikke-organisk.

TerveystaloPihlajalinna
Terveystalo, Webcast, Q1'26
Webcast4/24/2026, 7:30 AM

Terveystalo, Webcast, Q1'26

Terveystalo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/31/2026, 6:00 AM

Terveystalo Oyj: Changes in Terveystalo's Executive Team

Terveystalo
Regulatory press release3/24/2026, 12:00 PM

Terveystalo Oyj: Resolutions of the organising meeting of Terveystalo's Board of Directors

Terveystalo
Regulatory press release3/24/2026, 10:30 AM

Terveystalo Oyj: Terveystalo Plc: Resolutions of Annual General Meeting

Terveystalo
Regulatory press release3/11/2026, 10:00 AM

Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Iho

Terveystalo
Regulatory press release3/11/2026, 10:00 AM

Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Saviharju

Terveystalo
Regulatory press release3/11/2026, 10:00 AM

Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Pajunen

Terveystalo
Regulatory press release3/11/2026, 10:00 AM

Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Mäenalanen

Terveystalo
Regulatory press release2/27/2026, 7:30 AM

Terveystalo Oyj: Notice to the Annual General Meeting

Terveystalo
Regulatory press release2/27/2026, 7:00 AM

Terveystalo Oyj: Terveystalo's Annual Report 2025 published

Terveystalo
Regulatory press release2/16/2026, 1:00 PM

Terveystalo Oyj: Hilppa Rautpalo appointed Terveystalo's SVP, Human Resources and member of the Group Management Team

Terveystalo
Terveystalo Q4'25: Rentabilitet finder fodfæste i modvind på markedet
Research2/16/2026, 6:00 AM by
Roni Peuranheimo

Terveystalo Q4'25: Rentabilitet finder fodfæste i modvind på markedet

Terveystalos toplinje faldt mere end forventet, drevet af en fortsat udfordrende markedssituation på mange områder, men i betragtning af dette var rentabiliteten på et meget stærkt niveau.

Terveystalo
Terveystalo, Webcast, Q4'25
Webcast2/13/2026, 8:30 AM

Terveystalo, Webcast, Q4'25

Terveystalo
Regulatory press release2/13/2026, 7:05 AM

Terveystalo Oyj: Terveystalo Plc's Board of Directors has approved a new performance period covering years 2026-2028 of the long-term share-based incentive plan for key personnel

Terveystalo
Regulatory press release2/13/2026, 7:02 AM

Terveystalo Oyj: Proposals of Terveystalo's Board of Directors to the Annual General Meeting 2026

Terveystalo
Regulatory press release2/13/2026, 7:00 AM

Terveystalo Oyj: Terveystalo Group Financial Statements Release 2025: Strong profitability in an increasingly challenging market environment

Terveystalo
Terveystalo Q4'25 preview: Indtjeningsvæksten aftager i år
Analyst Comment2/5/2026, 5:00 AM by
Roni Peuranheimo

Terveystalo Q4'25 preview: Indtjeningsvæksten aftager i år

Vi estimerer, at indtjeningsvæksten vil aftage i 2026.

Terveystalo
Article1/31/2026, 8:00 AM by
Daniel Vähä-Antila

Udbytteudsigter 2026: Børsens udbytteafkast falder

Udbytteafkastet på Helsinki Børsen er faldende år-til-år. Der er udsigt til udbyttenedskæringer, men der er også højt udbytteafkast at finde hos udvalgte selskaber.

MandatumFortumNordea BankVerkkokauppa.comArvo SijoitusosuuskuntaTerveystaloPihlajalinnaMetsä BoardOriolaFiskarsTitaniumStora EnsoUPM-Kymmene
Forum discussions
Ronin’s comments on the performance of Terveystalo and Pihlajalinna’s competitor Mehiläinen Mehiläinen, a competitor to Terveystalo and Pihlajalinna, already published its annual report in February, but we will go into more detail about the company’s development in this comment. ...
4/1/2026, 6:11 AM
by Sijoittaja-alokas
14
Here is a company preview report from Roni on Terveystalo, which will release its Q1 results on Friday, April 24. The demand environment in the private healthcare market has been weak in the early part of the year based on several public data points. In addition to this, the spillover...
yesterday
by Sijoittaja-alokas
11
Hohde Group Acquisition Proceeds at FCCA: KKV – 7 Apr 26 Kuuleminen yrityskaupasta Terveystalo Healthcare Oy / Hohde Group Oy Kilpailu- ja kuluttajaviraston (KKV) tutkittavana on järjestely, jossa Terveystalo Healthcare Oy hankkii yksinomaisen määräysvallan Hohde Group Oy:ssä.
4/8/2026, 10:12 AM
by Roni Peuranheimo
11
Hi @jarree There hasn’t been any public comment, but considering the news from Pihlajalinna (here is their own news on the topic, which sheds a bit more light on the matter: Verohallinnon uusi tulkinta muuttaa osan työterveyspalveluista arvonlisäverollisiksi | Pihlajalinna ) I wouldn...
4/15/2026, 12:05 PM
by Roni Peuranheimo
10
OP raises its recommendation to “buy”. Nordnet Nordnet Tee säästämisestä osakkeisiin & rahastoihin hauskempaa. Sijoittaminen osakkeisiin, rahastoihin ja ETF:iin ilman tarpeettomia kuluja. Tervetuloa Suomen tyytyväisimpien sijoittajien joukkoon! Avaa tili jo tänään!
3/5/2026, 10:24 AM
by enska
9
A portion of occupational healthcare service fees will retroactively become subject to value-added tax (VAT) starting January 1, 2024. The taxes will be invoiced to customers. Näihin monen käyttämiin palveluihin verottaja iskee: Laskutetaan takautuvasti | Kauppalehti @Roni_Peuranheimo...
4/15/2026, 7:17 AM
by jarree
5
Here’s a clip of just under three minutes from Sijoituskästi about Terveystalo https://x.com/STNXfi/status/2039338142835053034
4/3/2026, 6:21 PM
by Sijoittaja-alokas
5
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.